Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418620 · ClinicalTrials.gov registry record · Phase 1
A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Participants
A Phase 1 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT06418620 is a Phase 1 study that has completed, run by Sanofi. The registered enrollment target is 9 participants.
The verdict
NCT06418620, a Phase 1 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of food on the bioavailability of venglustat and to assess the relative bioavailability of venglustat tablet swallowed whole with water versus a tablet chewed and then swallowed without water. Also, to evaluate the safety and tolerability of a single dose tablet of venglustat under fed (swallowed whole) and fasted (swallowed whole or chewed) conditions in healthy adult participants. The maximum duration for participants from screening is up to 63 days.
Interventions
- DRUG Venglustat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-06-18 |
| Est. Completion | 2020-08-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06418620
The ClinicalTrials.gov registry entry for NCT06418620 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venglustat is the first listed.
NCT06418620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06418620 about?
NCT06418620 is a clinical study titled "A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Participants". The purpose of this study is to assess the effect of food on the bioavailability of venglustat and to assess the relative bioavailability of venglustat tablet swallowed whole with water versus a tablet chewed and then swallowed without water. Also, to evaluate the safety and tolerability of a single...
What is the current status of trial NCT06418620?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2020-06-18. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT06418620?
The interventions under investigation include: Venglustat (DRUG).
Who is sponsoring clinical trial NCT06418620?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.